Percorrer por autor Syrjänen, Kari Subscrever estatísticas do autor Syrjänen, Kari

Índice: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

ou inserir as letras iniciais:  

Mostrar 1-16 de um total de 16 resultados.
DataTítuloAutor(es)TipoAcesso
Jan-2019Comparison of a new-generation fecal immunochemical test (FIT) with guaiac fecal occult blood test (gFOBT) in detecting colorectal neoplasia among colonoscopy-referral patientsGuimarães, Denise Peixoto; Fregnani, Jose Humberto; Reis, R. M., et al.ArtigoAcesso restrito autor
Jul-2013Competing-risks regression models in analysis of biomarkers as predictors of high-risk human papillomavirus (HPV) infection outcomes and incident CIN in the LAMS cohortSyrjänen, Stina; Longhato, Adhemar; Sarian, Luis O., et al.ArtigoAcesso restrito autor
2005Conventional Pap smear and liquid-based cytology as screening tools in low-resource settings in Latin America: experience of the Latin American screening studyLongatto, Adhemar; Maeda, Marina Yoshiê Sakamoto; Erzen, Mojca, et al.ArtigoAcesso restrito UMinho
2019HPV: a virus-dinosaur living among us?Longatto, Adhemar; Syrjänen, KariEditorial em revistaAcesso aberto
Dez-2009Immunosuppressive cytokine Interleukin-10 (IL-10) is up-regulated in high-grade CIN but not associated with high-risk human papillomavirus (HPV) at baseline, outcomes of HR-HPV infections or incident CIN in the LAMS cohortSyrjänen, Stina; Naud, Paulo; Sarian, Luis, et al.ArtigoAcesso restrito UMinho
2010Optional screening strategies for cervical cancer using standalone tests and their combinations among low- and medium-income populations in Latin America and Eastern EuropeSarian, Luis Otavio; Derchain, Sophie; Shabalova, Irena, et al.ArtigoAcesso aberto
Mai-2012Performance characteristics of Pap test, VIA, VILI, HR-HPV testing, cervicography, and colposcopy in diagnosis of significant cervical pathologyLongatto, Adhemar; Naud, Paulo; Derchain, Sophie F. M., et al.ArtigoAcesso restrito UMinho
Jul-2009Persistent high-risk human papillomavirus infections and other end-point markers of progressive cervical disease among women prospectively followed up in the New Independent States of the Former Soviet Union and the Latin American Screening study cohortsSyrjänen, Kari; Shabalova, Irena; Naud, Paulo, et al.ArtigoAcesso restrito autor
Abr-2017Physical state and copy numbers of HPV16 in oral asymptomatic infections that persisted or cleared during the 6-year follow-upLorenzi, Adriana; Rautava, Jaana; Kero, Katja, et al.ArtigoAcesso restrito autor
Fev-2008Prevalence of genital HPV infection among women screened for cervical cancerRama, Cristina Helena; Roteli-Martins, Cecilia Maria; Derchain, Sophie Françoise Mauricette, et al.ArtigoAcesso restrito UMinho
2009Smoking worsens the prognosis of mild abnormalities in cervical cytologyGuarisi, Renata; Sarian, Luis Otavio; Hammes, Luciano Serpa, et al.ArtigoAcesso restrito UMinho
Jun-2013The impact of breast cancer screening among younger women in the Barretos Region, BrazilDe Castro Mattos, Jacó Saraiva; Mauad, Edmundo Carvalho; Syrjänen, Kari, et al.ArtigoAcesso restrito UMinho
Fev-2010Up-regulation of 14-3-3sigma (Stratifin) is associated with high-grade CIN and high-risk human papillomavirus (HPV) at baseline but does not predict outcomes of HR-HPV infections or incident CIN in the LAMS studySyrjänen, Stina; Naud, Paulo; Sarian, Luis, et al.ArtigoAcesso aberto
Jul-2010Up-regulation of lipocalin 2 is associated with high-risk human papillomavirus and grade of cervical lesion at baseline but does not predict outcomes of infections or incident cervical intraepithelial neoplasiaSyrjänen, Stina; Naud, Paulo; Sarian, Luis, et al.ArtigoAcesso restrito UMinho
Dez-2009Up-regulation of plasminogen activator inhibitor-2 is associated with high-risk HPV and grade of cervical lesion at baseline but does not predict outcomes of high-risk HPV infections or incident CINSyrjänen, Stina; Naud, Paulo; Sarian, Luis, et al.ArtigoAcesso restrito UMinho
2008Value of conventional pap smear, liquid-based cytology, visual inspection and human papillomavirus testing as optional screening tools among latin american women <35 and ≥ 35 years of age: experience from the Latin American Screening StudySyrjänen, Kari; Derchain, Sophie; Roteli-Martins, Cecilia, et al.ArtigoAcesso restrito autor